review Open AccessTop 1% cited
EAU-EANM-ESTRO-ESUR-ISUP-SIOG Guidelines on Prostate Cancer—2024 Update. Part I: Screening, Diagnosis, and Local Treatment with Curative Intent
European Urology · 2024 · Vol. 86(2) · pp. 148–163
Philip Cornford✉(Royal Liverpool and Broadgreen University Hospital NHS Trust)Roderick C.N. van den Bergh(Erasmus MC)Erik BriersThomas Van den Broeck(KU Leuven)Oliver Brunckhorst(King's College London)Julie Darraugh(European Association of Urology)Daniel Eberli(University Hospital of Zurich)Gert De Meerleer(KU Leuven)Maria De Santis(Medical University of Vienna)Andrea Farolfi(Azienda USL di Bologna)Giorgio Gandaglia(Vita-Salute San Raffaele University)Silke Gillessen(Institute of Oncology Research)Nikolaos Grivas(The Netherlands Cancer Institute)Ann Henry(University of Leeds)Michael Lardas(Metropolitan Hospital)Geert J.L.H. van Leenders(Erasmus MC)Matthew LiewEstefanía Linares(Hospital Universitario La Paz)Jan Oldenburg(University of Oslo)Inge M. van Oort(Radboud University Nijmegen)Daniela E. Oprea‐Lager(Amsterdam University Medical Centers)Guillaume Ploussard(Lyon Genou Centre Albert Trillat)Matthew J. Roberts(Royal Brisbane and Women's Hospital)Olivier Rouvière(Université Claude Bernard Lyon 1)Ivo G. Schoots(Erasmus MC Cancer Institute)Natasha Schouten(European Association of Urology)Emma Jane Smith(European Association of Urology)Johan Stranne(Sahlgrenska University Hospital)Thomas Wiegel(University Hospital Ulm)Peter-Paul Willemse(University Medical Center Utrecht)Derya Tilki(Universität Hamburg)
Prostate Cancer Diagnosis and TreatmentProstate Cancer Treatment and ResearchUrologic and reproductive health conditionsMedicineProstate cancerRadiation therapyMedical physicsCancerRadiologyInternal medicine
MeSH terms
HumansMaleProstatic NeoplasmsEarly Detection of Cancer
Funding
- Amgen
- Bristol-Myers Squibb
- Pfizer
- AstraZeneca
- American Society of Clinical Oncology
- Boston Scientific Corporation
- Myriad Genetics
- Astellas Pharma
- Deutsche Gesellschaft für Urologie
- Ipsen
- Unicancer
- Novartis Pharma
- Daiichi Sankyo Europe
- Cilag
Citations
903
FWCI
376.20
field-weighted impact
References
145
Percentile
100%
vs. same field & year
Citations per year
References
Accuracy of Magnetic Resonance Imaging for Local Staging of Prostate Cancer: A Diagnostic Meta-analysis
European Urology · 2015 · 650 citations
The Mini‐Cog as a Screen for Dementia: Validation in a Population‐Based Sample
Journal of the American Geriatrics Society · 2003 · 1,309 citations
The 2005 International Society of Urological Pathology (ISUP) Consensus Conference on Gleason Grading of Prostatic Carcinoma
The American Journal of Surgical Pathology · 2005 · 2,756 citations
Going from evidence to recommendations
BMJ · 2008 · 1,776 citations
Incidence of Late Rectal and Urinary Toxicities After Three-Dimensional Conformal Radiotherapy and Intensity-Modulated Radiotherapy for Localized Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics · 2008 · 735 citations
Gait Speed and Survival in Older Adults
JAMA · 2011 · 4,338 citations
TNM Classification of Malignant Tumors
The American Journal of Surgical Pathology · 1998 · 6,357 citations
Androgen Suppression Combined with Elective Nodal and Dose Escalated Radiation Therapy (the ASCENDE-RT Trial): An Analysis of Survival Endpoints for a Randomized Trial Comparing a Low-Dose-Rate Brachytherapy Boost to a Dose-Escalated External Beam Boost for High- and Intermediate-risk Prostate Cancer
International Journal of Radiation Oncology*Biology*Physics · 2016 · 718 citations
Citation Network
How this paper connects to the literature. Drag to explore, click any node to open that paper.